Phyteau

United States
Delaware, Lewes, United States
(505)216-6250 ★

Company profile

Phyteau company profile

Phyteau is developing a new class of therapeutics for diabetes, obesity, weight-loss, and related metabolic condition like NAFLD and NASH. The company's therapeutics work in the intestines where they trigger key cellular receptors causing the release of therapeutic levels of key metabolic hormones, like GLP-1, PYY and CCK. The hormones work naturally and safely to control blood sugar, appetite, food intake, and metabolism. The company continues to develop new solutions to help people around the world suffering from metabolic diseases. Phyteau was founded on 2017 and is headquartered in Santa Fe, New Mexico.

Business identity

Contact email
[email protected]
Phone number
(505)216-6250
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$0+
Founded
2017-01-01

Headquarters

Headquarters
Delaware, Lewes, United States
Postal code
19958
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Last funding
Seed / 2017-05-08
Last equity funding
Seed
Investors
2
Lead investors
1
Founders
3
Articles
1

Founders and investors

Founders

Bonn MacyJanine LehmannStephen Pandol

Lead investors

SOSV

Investors

RebelBioSOSV

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.